Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy

por Millis, Sherri Z., Ejadi, Samuel, Demeure, Michael J.
Publicado no Biomark Cancer (2015)

HER2 expression status in diverse cancers: review of results from 37,992 patients

por Yan, Min, Schwaederle, Maria, Arguello, David, Millis, Sherri Z., Gatalica, Zoran, Kurzrock, Razelle
Publicado no Cancer Metastasis Rev (2015)

Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis

por Borazanci, Erkut, Millis, Sherri Z., Kimbrough, Jeffery, Doll, Nancy, Von Hoff, Daniel, Ramanathan, Ramesh K.
Publicado no J Gastrointest Oncol (2017)

Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation

por Ang, Celina, Stollman, Aryeh, Zhu, Hongfa, Sarpel, Umut, Scarborough, Bethann, Sahni, Gagan, Millis, Sherri Z.
Publicado no Case Rep Oncol (2017)

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions

por Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Publicado no Oncologist (2020)

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

por Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Publicado no Oncologist (2021)

Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequence.

por Kirwan, Angie F, Bibby, Ashley C, Mvilongo, Thierry, Riedel, Heimo, Burke, Thomas, Millis, Sherri Z, Parissenti, Amadeo M
Publicado em 2003

Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of t...

por Barth, Peter, Dulaimi Al-Saleem, Essel, Edwards, Kristin W., Millis, Sherri Z., Wong, Yu-Ning, Geynisman, Daniel M.
Publicado no Case Rep Oncol Med (2015)

Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: Analysis of 1806 cases

por Gatalica, Zoran, Millis, Sherri Z., Vranic, Semir, Bender, Ryan, Basu, Gargi D., Voss, Andreas, Von Hoff, Daniel D.
Publicado no Oncotarget (2014)

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities

por Millis, Sherri Z., Jardim, Denis L., Albacker, Lee, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Kurzrock, Razelle
Publicado no Cancer (2018)

Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets

por Movva, Sujana, Wen, Wenhsiang, Chen, Wangjuh, Millis, Sherri Z., Gatalica, Zoran, Reddy, Sandeep, von Mehren, Margaret, Van Tine, Brian A.
Publicado no Oncotarget (2015)

Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens

por Hay, Margaret A., Severson, Eric A., Miller, Vincent A., Liebner, David A., Vergilio, Jo-Anne, Millis, Sherri Z., Chen, James L.
Publicado no JCO Precis Oncol (2020)

Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review

por Borazanci, Erkut, Millis, Sherri Z, Korn, Ron, Han, Haiyong, Whatcott, Clifford J, Gatalica, Zoran, Barrett, Michael T, Cridebring, Derek, Von Hoff, Daniel D
Publicado no World J Gastrointest Oncol (2015)

Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability

por Bieg-Bourne, Cheyennedra C., Millis, Sherri Z., Piccioni, David E., Fanta, Paul T., Goldberg, Michael E., Chmielecki, Juliann, Parker, Barbara A., Kurzrock, Razelle
Publicado no Cancer Res (2017)

Recurrent secondary genomic alterations in desmoplastic small round cell tumors

por Chow, Warren A., Yee, Jiing-Kuan, Tsark, Walter, Wu, Xiwei, Qin, Hanjun, Guan, Min, Ross, Jeffrey S., Ali, Siraj M., Millis, Sherri Z.
Publicado no BMC Med Genet (2020)

Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine

por Jiao, Guan-Sheng, Cregar, Lynne, Wang, Jinzhi, Millis, Sherri Z., Tang, Cho, O'Malley, Sean, Johnson, Alan T., Sareth, Sina, Larson, Jason, Thomas, Gary
Publicado em 2006

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1

por Gatalica, Zoran, Bilalovic, Nurija, Palazzo, Juan P., Bender, Ryan P., Swensen, Jeffrey, Millis, Sherri Z., Vranic, Semir, Von Hoff, Daniel, Arceci, Robert J.
Publicado no Oncotarget (2015)

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target

por Seligson, Nathan D., Maradiaga, Richard D., Stets, Colin M., Katzenstein, Howard M., Millis, Sherri Z., Rogers, Alan, Hays, John L., Chen, James L.
Publicado no NPJ Precis Oncol (2021)

Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers

por Wen, Wenhsiang, Chen, Wangjuh (Sting), Xiao, Nick, Bender, Ryan, Ghazalpour, Anatole, Tan, Zheng, Swensen, Jeffrey, Millis, Sherri Z., Basu, Gargi, Gatalica, Zoran, Press, Michael F.
Publicado no J Mol Diagn (2015)

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

por Ang, Celina, Klempner, Samuel J., Ali, Siraj M., Madison, Russell, Ross, Jeffrey S., Severson, Eric A., Fabrizio, David, Goodman, Aaron, Kurzrock, Razelle, Suh, James, Millis, Sherri Z.
Publicado no Oncotarget (2019)